NSP 2017-2022 Mid Term Review: Summary of Preliminary Findings

The South African National AIDS Council (SANAC)

The National Strategic Plan for HIV, TB and STIs (NSP) 2017-2022 Mid Term Review (MTR) was an in-depth analysis of the NSP implementation, with the aim to illustrate progress made towards reaching the NSP targets across the eight NSP goals. The review focused on the first half of the NSP term (2017 to 2019) and documented emerging issues and opportunities, lessons learnt, gaps and challenges encountered. This summary of findings focused on the first four goals of the NSP and presents key data pertaining to women in South Africa, using 2016 as the baseline year and 2018 for the most recent data.

The focus on young and adult women in this summary is important because women are disproportionately affected by HIV in South Africa. In 2018, 21% of women were estimated to be living with HIV, compared to 13% of men. Furthermore, the HIV prevalence among young women is three times greater than that of young men. In 2018, 500,000 young women aged 15 to 24 years were living with HIV, compared to 167,000 young men.

The review synthesised evidence from primary data, collected through key informant interviews at national and provincial levels, and desk review of secondary data from diverse sources. SANAC NSP Reference Group, Strategic Information Technical Task Team, Civil Society, and other stakeholders were instrumental to ensuring high-quality review and validation of findings. The MTR findings will:

  • inform targeted implementation of the NSP for the remaining period ending March 2022
  • provide recommendations for enhanced performance towards achievement of the NSP targets by the end of the NSP term.
July 1, 2020
Year of publication
2020
Resource types
Infographics, Reports and Fact sheets, Systematic reviews
Countries
Tags
adolescent girls and young women (AGYW), HIV prevalence and incidence

Similar Resources

Many countries are working to reduce or eliminate mother-to-child transmission (MTCT) of HIV. Prevention efforts have been conceptualized as steps in a cascade but cascade completion rates during and after pregnancy are low.

Remarkable progress is being made on HIV treatment. Ahead of World AIDS Day, UNAIDS has launched a new report showing that access to treatment has risen significantly. In 2000, just 685 000 people living with HIV had access to antiretroviral therapy.

This supplement to Acta Paediatrica presents a series of meta-analyses and systematic literature reviews examining a variety of health effects potentially related to breastfeeding.

This paper documents the development of the global and national monitoring and reporting systems for PMTCT and paediatric HIV care and treatment programmes, achievements and remaining challenges.

The heightened risk of HIV infection among female sex workers (FSWs) has been clearly established across settings. In sub-Saharan Africa (SSA), FSWs have an estimated HIV prevalence of 36.9% as compared to 7.4% in the general adult female population. In the Iringa region of Tanzania, a…

To understand the uptake of HIV services by adolescent women, the authors conducted a retrospective analysis of patient-level data (2011–2013) on services for antenatal care (ANC) and prevention of mother-to-child transmission (PMTCT) in 36 facilities in 5 districts in Zimbabwe.

This issue of the Southern African HIV Clinicians Society's "HIV Nursing Matters" online magazine focuses on vulnerable populations, including TB in prisons and intimate partner violence in the context of HIV.

This issue of the Southern African HIV Clinicians Society's "HIV Nursing Matters" online magazine focuses on key populations.

The incidence of HIV infection in young women in Africa is very high. We did a large-scale community-wide phylogenetic study to examine the underlying HIV transmission dynamics and the source and consequences of high rates of HIV infection in young women in South Africa.

Evidence shows that HIV prevalence among young women in sub-Saharan Africa increases almost five-fold between ages 15 and 24, with almost a quarter of young women infected by their early-to mid-20s.